| | | September 20, 2023 Hey traders! It's Michael here with the Stock Dork Cheat Sheet: Premarket Report, your go-to guide for the day's biggest trading news and hottest premarket stocks! Today is Wednesday, September 20th. I hope you have a great day in the market. Now, let's get ready to trade! |
| Stocks dipped on Tuesday, with the Nasdaq and S&P 500 posting matching losses of 0.2%. The Dow fell 0.3%, and the small-cap Russell 2K closed 0.4% lower. Today, futures are ticking higher in early trading. S&P 500 contracts are currently hovering around 0.2%. ALERT : Explosive Swing Trade Setup 💥 A tiny stock with a growing position in a high-octane growth industry could be on the verge of a massive move higher. An in-depth technical analysis found this up-and-coming ticker could have potential to achieve intermediate target gains of up 113.3% from its current position. There are also signs that volume is beginning to release from the accumulation phase, so a big breakout could be coming soon. With increasing volatility and enormous upside potential, this stock could be on course for an explosive rally higher in the coming days. Get a Detailed Report on this Promising Stock Here 🏛 Fed Meeting on DeckThe Federal Reserve's Open Markets Committee's Board of Governors will host its September meeting in today's session, followed by a statement from chairman Jerome Powell. Experts anticipated the central bank will hold rates steady this month. However, there's still a strong possibility we could see another hike before the end of the year. |
| Cambridge Bancorp [CATC] - Last Close: $48.59 A merger deal is boosting shares of Cambridge Bancorp. Late Tuesday, the company announced a definitive agreement to merge with Eastern Bankshares [EBC] in an all-stock deal worth $510 million. Under the terms of the deal, Cambridge shareholders will receive 4.956 shares of EBC in exchange for each share of CATC they hold. The deal has been approved by both companies' boards, and it's expected to close in Q1, 2024. CATC is up 18.7% on the merger news. My Take: CATC got a nice little bump out of this news, but the stock wasn't doing well beforehand. I would imagine most of the upside from this deal is already priced in. Exscientia [EXAI] - Last Close: $5.06 Exscientia just landed a new collaborative partnership. This morning, the company announced a new drug discovery collaboration with Merck KGaA to develop caner, neuroinflammatory, and immunology drugs. The research will heavily leverage Exscientia's artificial intelligence technology. In exchange, Exscientia will get $20 million cash upfront, plus up to $674 million in potential milestone payments. The collaboration will initially focus on three targets, but the companies have plans to expand it into other disease areas over time. EXAI is one of today's top-performing premarket stocks with a 27.6% gain. My Take: EXAI has struggled as of late. It's down nearly 50% from its recent peak, but this news could provide the shot in the arm it needs to pivot. Blue Jay Diagnostics [BJDX] - Last Close: $3.10 An analyst upgrade is lifting shares of Blue Jay Diagnostics. Earlier this week, analysis at Refinitiv/Verus upgraded BJDX from "sell" to "hold." Blue Jay has struggled as of late. At the beginning of August, it was trading for upwards of $7.50. However, shares are rebounding suddenly in the premarket. BJDX is up 13.2%. My Take: BJDX could be in rebound mode, but I am not seeing the trading volume spike I'd expect for a stock that's preparing to pivot. There could be opportunity here, but I am not sold we've hit bottom just yet. Fresh Tracks Therapeutics [FRTX] - Last Close: $0.5829 Fresh Tracks is up after an announcement. Late Tuesday, the biotech said its board had approved a plan for the liquidation and dissolution of the company. Fresh Tracks intends to distribute all remaining cash to shareholders. It will host a shareholder meeting in Q4 for a final vote on the matter. The company expects to make liquidating distributions to shareholders ranging from $5 million to $7 million.
FRTX is one of today's top stocks with a 52.6% gain. My Take: Well, sounds like FRTX is closing up its doors, so it's definitely not a long-term play. But, there could be short-term opportunities for savvy swing traders. GainersTranscode Therapeutics [RNAZ] >> +44.9%Lilium [LILMW] >> +24.5%Histogen [HSTP] >> +34.1%Ebet [EBET] >> +28.3%DeclinersARS Pharma [SPRY] >> (59.4%) Icecure Medical [ICCM] >> (41.1%)Connexa Sports Tech [CNXA] >> (34.4%)Seelos Therapeutics [SEEL] >> (62.7%) General Mills, Inc. [GIS] ... AM
Lifezone Metals Limited [LZM] ... AM
Fedex Corporation [FDX] ... PM
KB Home [KBH] ... PM Fed interest-rate decision ... 2:00pFed Chair Powell press conference ... 2:30p |
| Thanks for reading! Don't forget, I'm always eager to hear from you. Reply to this email with your questions, comments, or general feedback, and I'll get back to you as soon as I can. Wishing you big returns on your investments this week, as always! - Michael "The Stock Dork" Taylor Disclaimer© 2023 TheStockDork.com. All rights reserved. This message was sent by TheStockDork.com and may contain commercial elements such as advertising. Read full terms here. |
|
|
|
| | |
|
